Narcolepsy Treatment Market

Posted by ahila on April 26th, 2018

Global Narcolepsy Treatment Market :Narcolepsy is a lifelong sleeping disorder which makes you feel immensely tired sometimes with uncontrollable sudden sleep attacks in severe cases. It is a disabling condition which is characterized by three different symptoms such as excessive daytime cataplexy, sleepiness and irresistible sleep episodes, fluctuating automatic behaviours. Narcolepsy generally begins between 15 to 25 years and it can be evident at any age. Global Narcolepsy Treatment Market is untreated and undiagnosed in many cases.

 

Factors that are driving the growth of Global Narcolepsy Treatment Market are growing prevalence of various sleeping disorders including narcolepsy, increase awareness about the sleep disorders. Furthermore, increasing demand for advanced diagnostics and therapeutics to treat sleeping disorders and rise in geriatric population. A narcoleptic disorder is proportionately prevalent to Parkinson’s disease, according to the WHO statistics, more than 3 million people are suffering from narcolepsy across the globe. However, stringent regulatory framework, unawareness about the disorder in underdeveloped countries, abuse usage of the drugs, delayed or undiagnosed of the narcolepsy are the few factors which are hampering the growth of narcolepsy treatment market.

     A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-narcolepsy-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

The narcolepsy treatment market is classified on the basis of disorder, drug class, distribution channel, and geography.

Based on type of disorder, the narcolepsy treatment market is segmented into the following:

  • Secondary Narcolepsy
  • Narcolepsy with cataplexy
  • Narcolepsy without cataplexy

Based on drugs, the narcolepsy treatment market is segmented into the following:

  • Amphetamines
  • Methylphenidate
  • Modafinil
  • MAO-B Inhibitors (Selegiline)
  • Tricyclic Anti-Depressants (TCA)
  • Selective Serotonin Reuptake Inhibitors (SSRI)
  • Monoamino Oxidase Type-A (MAO-A) inhibitors

Based on distribution channel, the Narcolepsy Treatment Market is segmented into the following:

  • Hospital pharmacies
  • Retail Pharmacies
  • Online Pharmacies

   To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-narcolepsy-treatment-market/#ulp-c654SbFYO64MsOhu

Like it? Share it!


ahila

About the Author

ahila
Joined: March 20th, 2018
Articles Posted: 168

More by this author